Skip to main content
Back
SBRA logo

Sabra Health Care REIT, Inc.

Data quality: 100%
SBRA
NASDAQ Real Estate REIT - Healthcare Facilities
$19.84
▲ $0.11 (0.56%)
Mkt Cap: 5.00B
Day Range
$19.71 $19.94
52-Week Range
$15.75 $21.07
Volume
2,357,063
50D / 200D Avg
$19.74 / $18.86
Prev Close
$19.73

Quick Summary

Price History

Financial Trends

Peer Comparison

vs Real Estate sector median (361 peers)

Metric Stock Sector Median
P/E 32.2 11.2
P/B 1.8 0.9
ROE % 5.6 6.1
Net Margin % 20.1 19.9
Rev Growth 5Y % 8.0 7.0
D/E 0.9 0.9

Analyst Price Target

Hold
$21.33 +7.5%
Low: $21.00 High: $22.00
Forward P/E
28.58
Forward EPS
$0.69
EPS Growth (est.)
+0.0%
Est. Revenue
844.30M

Earnings Estimates

Period EPS Est. Revenue Est. Analysts
FY2030 $0.00
$0.00 – $0.00
1.37B 0
FY2029 $0.84
$0.79 – $0.90
1.09B 1
FY2028 $0.81
$0.79 – $0.84
892.15M 2

Earnings Surprises

Last 8 quarters
Quarter Est. EPS Actual EPS Surprise
2026-02-12 $0.16 $0.38 +131.6%
2025-11-05 $0.38 $0.38 0.0%
2025-08-04 $0.37 $0.38 +2.7%
2025-05-05 $0.36 $0.37 +2.8%
2025-02-19 $0.36 $0.36 0.0%
2024-10-31 $0.36 $0.37 +2.8%
2024-08-07 $0.35 $0.36 +2.9%
2024-05-08 $0.34 $0.35 +2.9%

Dividend History

7 yr streak

Yield

0.06%

Payout Ratio

1.86%

Growth (3Y)

0.00%

Growth (5Y)

-2.33%

Ex-Date Payment Date Amount Yield
Feb 13, 2026 Feb 27, 2026 $0.30 5.95%
Nov 17, 2025 Nov 28, 2025 $0.30 6.46%
Aug 15, 2025 Aug 29, 2025 $0.30 6.50%
May 16, 2025 May 30, 2025 $0.30 6.72%
Feb 14, 2025 Feb 28, 2025 $0.30 7.26%
Nov 15, 2024 Nov 29, 2024 $0.30 6.60%
Aug 19, 2024 Aug 30, 2024 $0.30 7.52%
May 17, 2024 May 31, 2024 $0.30 8.37%
Feb 12, 2024 Feb 29, 2024 $0.30 8.83%
Nov 16, 2023 Nov 30, 2023 $0.30 8.44%
Aug 16, 2023 Aug 31, 2023 $0.30 10.00%
May 15, 2023 May 31, 2023 $0.30 10.67%
Feb 10, 2023 Feb 28, 2023 $0.30 9.14%
Nov 16, 2022 Nov 30, 2022 $0.30 10.14%
Aug 16, 2022 Aug 31, 2022 $0.30 7.53%
May 13, 2022 May 31, 2022 $0.30 9.39%
Feb 10, 2022 Feb 28, 2022 $0.30 9.37%
Nov 15, 2021 Nov 30, 2021 $0.30 8.28%
Aug 16, 2021 Aug 31, 2021 $0.30 7.35%
May 14, 2021 May 28, 2021 $0.30 7.02%

Key Takeaways

Revenue grew 7.99% annually over 5 years — modest growth
Earnings grew 22.81% over the past year
Net margin of 20.09% shows strong profitability
Generating 348.61M in free cash flow
P/E of 32.15 — premium valuation
Cash machine — converts 224.03% of earnings into free cash flow

Growth

Revenue Growth (5Y)
7.99%
Revenue (1Y)10.15%
Earnings (1Y)22.81%
FCF Growth (3Y)7.70%

Quality

Return on Equity
5.59%
ROIC3.68%
Net Margin20.09%
Op. Margin34.06%

Safety

Debt / Equity
0.90
Current Ratio0.15
Interest Coverage2.35

Valuation

P/E Ratio
32.15
Forward P/E28.58
P/B Ratio1.77
EV/EBITDA28.35
Dividend Yield0.06%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 10.15% Revenue Growth (3Y) 9.38%
Earnings Growth (1Y) 22.81% Earnings Growth (3Y) 236.33%
Revenue Growth (5Y) 7.99% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 774.63M Net Income (TTM) 155.61M
ROE 5.59% ROA 2.83%
Gross Margin 65.00% Operating Margin 34.06%
Net Margin 20.09% Free Cash Flow (TTM) 348.61M
ROIC 3.68% FCF Growth (3Y) 7.70%
Safety
Debt / Equity 0.90 Current Ratio 0.15
Interest Coverage 2.35
Dividends
Dividend Yield 0.06% Payout Ratio 1.86%
Dividend Growth (3Y) 0.00% Dividend Growth (5Y) -2.33%
Consecutive Div Years 7 yrs
Valuation
P/E Ratio 32.15 Forward P/E 28.58
P/B Ratio 1.77 P/S Ratio 6.46
PEG Ratio 1.59 Forward PEG N/A
EV/EBITDA 28.35 Fwd EV/EBITDA 19.29
Forward P/S 5.93 Fwd Earnings Yield 3.50%
FCF Yield 6.97%
Market Cap 5.00B Enterprise Value 7.48B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 774.63M 703.24M 647.51M 624.81M 569.55M
Net Income 155.61M 126.71M 13.76M -77.61M -113.26M
EPS (Diluted) 0.64 0.54 0.06 -0.34 -0.52
Gross Profit 503.53M 476.15M 452.27M 462.20M 428.34M
Operating Income 263.87M 257.03M 221.71M 234.84M 210.75M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 5.49B 5.30B 5.39B 5.75B 5.97B
Total Liabilities 2.67B 2.56B 2.58B 2.69B 2.59B
Shareholders' Equity 2.82B 2.74B 2.80B 3.06B 3.38B
Total Debt 2.55B 2.44B 2.45B 2.55B 2.44B
Cash & Equivalents 71.54M 60.47M 41.29M 49.31M 112.00M
Current Assets 182.83M 198.09M 180.53M 201.84M 253.99M
Current Liabilities 1.26B 224.45M 231.41M 339.24M 142.99M

Strategy Scores

This stock passed the criteria for 1 strategy

Score = fit strength (0–100)
Rank = position among all matches
#455 of 1049
47

Recent Activity

Entered Cash Flow Compounder
Mar 24, 2026